Department of Bioengineering and Therapeutic Sciences

Implantable Artificial Kidney Moves Closer to Reality

Mon Nov 13, 2017

A Quest: Insulin-Releasing Implant For Type-1 Diabetes

Tue Nov 7, 2017

Novel diabetes treatment developed in Desai Lab to power SF-area startup

Thu Oct 19, 2017

Encellin

The cell encapsulation device (right) that is being developed by Encellin, a San Francisco–based biotechnology company.

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

Celebrating Hubert Sylvester

Mon Oct 16, 2017

Customer service expert, Hubert Sylvester

The Department of Bioengineering and Therapeutic Sciences (BTS) is celebrating Hubert Sylvester on the occasion of his 35th employment anniversary at UCSF.

Silicon isn’t just for computers. It can make a pretty good kidney, too.

Mon Oct 9, 2017

Wired magazine visits The Kidney Project

Fri Oct 6, 2017

Elisabeth Fall

Shuvo Roy, PhD, and researcher Anusree Oruganti.

Kidney failure is a debilitating and ultimately deadly illness, and a health policy crisis. With 468,000 people on dialysis in the U.S., costing the government $31 billion dollars a year, very little money is spent on researching alternatives to current treatments.

Update from the Dean - September 2017

Wed Sep 20, 2017

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products...

Guo applies curiosity and collaboration to research

Thu Sep 14, 2017

Su Guo, PhD

“There are lots of important problems. Only attack those for which you can divine simple experiments with clear answers.”—Julius Axelrod

Giacomini to receive North American Scientific Achievement Award

Tue Sep 5, 2017

Noah Berger

Kathleen Giacomini, PhD

Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX).

Using antibiotics to stop contamination in cell cultures changes them, study finds

Thu Aug 31, 2017

Ann Hane Ryu, a graduate student in the lab of Nadav Ahituv, PhD, works with cell cultures.

The common lab practice of adding antibiotics to cell cultures to prevent contamination can actually induce genetic changes in the cells, a paper senior-authored by Nadav Ahituv, PhD, found. Ahituv is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department...

Department of Bioengineering and Therapeutic Sciences

Pages